Xylazine 10%

Xylazine is an α2-adrenergic agonist with analgesic, sedative, and muscle relaxant properties. Its sedative and analgesic activity is related to central nervous system depression. The muscle relaxant effect is based on the inhibition of intraneural impulse transmission in the central nervous system; the main effects develop within 10 to 15 minutes after intramuscular injection and within 3 to 5 minutes after intravenous injection.

BENEFITS:

•High safety in its use, both for the veterinarian and for the animal.
•Sedation is more successful if the animal is calmed before the anesthetic is administered.
•It allows for everything from the management of minor interventions to the use of general anesthesia in major interventions.
•Using Xylazine 10% Cheminova, there is a marked saving of anesthetic.

DOSE:

Depending on the class and degree of desired effect, the following are recommended:

the following doses:

Intravenous route: 0.5 to 1.1 mg/kg of body weight

(equivalent to 0.25-0.55 mL/50 kg of body weight).

Intramuscular route: 1 to 2 mg/kg of body weight

(equivalent to 0.5-1 mL/50 kg of body weight).

The dose depends on the degree of sedation sought and the time.

duration of the effect.

Its sale requires a prescription.